“Targeting JAK STAT Signaling: Ruxolitinib Cream in the Management of Concurrent Vitiligo and Discoid Lupus Erythematosus”. Dermatology Reports (September 11, 2025). Accessed October 9, 2025. https://journals.pagepress.org/dr/article/view/10458.